Provides an erectile dysfunction product via telehealth.
Industry: Health Care
Latest Trade: $2.52 +0.15 (+6.3%)
First Day Return: 0.0%
Return from IPO: -96.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/13/2023 |
Offer Price | $4.00 |
Price Range $4.00 - $4.00 | |
Offer Shares (mm) | 1.3 |
Deal Size ($mm) | $5 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 03/20/2023 |
Offer Price | $4.00 |
Price Range $4.00 - $4.00 | |
Offer Shares (mm) | 1.3 |
Deal Size ($mm) | $5 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Boustead Securities |
Sutter Securities |
Company Data | |
---|---|
Headquarters | Dallas, TX, United States |
Founded | 2021 |
Employees at IPO | 3 |
Website www.MangoRX.com |